Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLA | P06280 | 1/20 | 0.70 |
| ▸ | KMT2A | Q03164 | 9/20 | 0.62 |
| ▸ | ATM | Q13315 | 1/20 | 0.62 |
| ▸ | POLB | P06746 | 2/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.57 |
| ▸ | HPGD | P15428 | 1/20 | 0.57 |
| ▸ | CA12 | O43570 | 2/20 | 0.53 |
| ▸ | CA1 | P00915 | 2/20 | 0.53 |
| ▸ | CA9 | Q16790 | 2/20 | 0.53 |
| ▸ | LMNA | P02545 | 2/20 | 0.53 |
| ▸ | CA2 | P00918 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28586623 | 0.85 | GLA (0.74) | GLAKMT2AATMPOLBSMN1; SMN2 | |
| SCHEMBL6175746 | 0.82 | GLA (1.00) | GLAKMT2AATMPOLBSMN1; SMN2 | |
| SCHEMBL2031643 | 0.77 | KMT2A (1.00) | GLAKMT2AATMPOLBSMN1; SMN2 | |
| SCHEMBL32668241 | 0.77 | POLB (0.70) | GLAKMT2AATMPOLBSMN1; SMN2 | |
| SCHEMBL21001234 | 0.76 | ALDH1A1 (0.55) | KMT2ASMN1; SMN2HPGDALDH1A1MEN1 | |
| SCHEMBL6284986 | 0.76 | KMT2A (0.64) | KMT2APOLBSMN1; SMN2CA1LMNA | |
| SCHEMBL11478927 | 0.76 | CA12 (0.67) | GLAKMT2AATMPOLBCA12 | |
| SCHEMBL12444397 | 0.73 | POLB (1.00) | GLAKMT2AATMPOLBHPGD | |
| SCHEMBL8542788 | 0.73 | ALDH1A1 (0.47) | KMT2APOLBSMN1; SMN2HPGDLMNA | |
| SCHEMBL19387227 | 0.73 | ALDH1A1 (0.60) | GLAKMT2AATMPOLBSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9658234-B2 | Method for analysis of compounds with amino group and analytical reagent therefor | AJINOMOTO CO., INC. (JP) | 2017-05-23 | — | — | US | disclosed |
| US-20160139134-A1 | METHOD FOR ANALYSIS OF COMPOUNDS WITH AMINO GROUP AND ANALYTICAL REAGENT THEREFOR | AJINOMOTO CO., INC. (JP) | 2016-05-19 | — | — | US | disclosed |
| US-9274123-B2 | Method for analysis of compounds with amino group and analytical reagent therefor | AJINOMOTO CO., INC. (JP) | 2016-03-01 | — | — | US | disclosed |
| EP-2317307-B1 | Method of analyzing amino- and/or imino-functional compounds, and analytical reagent | AJINOMOTO KK (JP) | 2013-11-20 | — | — | EP | disclosed |
| EP-1475632-B1 | METHOD OF ANALYZING AMINOFUNCTIONAL COMPOUND AND ANALYTICAL REAGENT | AJINOMOTO KK (JP) | 2013-05-22 | — | — | EP | disclosed |
| EP-2336763-A1 | Method for analysis of compounds with amino group and analytical reagent thereof | Ajinomoto Co., Inc. (JP) | 2011-06-22 | — | — | EP | disclosed |
| EP-2317307-A2 | Method of analyzing amino- and/or imino-functional compounds, and analytical reagent | Ajinomoto Co., Inc. (JP) | 2011-05-04 | — | — | EP | disclosed |
| US-20060286673-A1 | Method for analysis of compounds with amino group and analytical reagent therefor | AJINOMOTO CO. INC (JP) | 2006-12-21 | — | — | US | disclosed |
| US-7148069-B2 | Method for analysis of compounds with amino group and analytical reagent therefor | AJINOMOTO CO., INC. (JP) | 2006-12-12 | — | — | US | disclosed |
| US-20050079624-A1 | Method for analysis of compounds with amino group and analytical reagent therefor | AJINOMOTO CO., INC (JP) | 2005-04-14 | — | — | US | disclosed |
| EP-1475632-A1 | METHOD OF ANALYZING AMINOFUNCTIONAL COMPOUND AND ANALYTICAL REAGENT | Ajinomoto Co., Inc. (JP) | 2004-11-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160139134-A1 | METHOD FOR ANALYSIS OF COMPOUNDS WITH AMINO GROUP AND ANALYTICAL REAGENT THEREFOR | CTH, VIP, SLC7A11 | GLA 4584/4885KMT2A 1434/4885ATM 4654/4885 |
| US-20050079624-A1 | Method for analysis of compounds with amino group and analytical reagent therefor | CTH, VIP, SLC7A11 | GLA 4584/4885KMT2A 1434/4885ATM 4654/4885 |
| US-20060286673-A1 | Method for analysis of compounds with amino group and analytical reagent therefor | CTH, VIP, SLC7A11 | GLA 4584/4885KMT2A 1434/4885ATM 4654/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.